AveXis, Inc. Common Stock

$96.10 +$0.11 +0.11%

Own 2 of AVXS at $94.81

+$1.28 (+1.36%)

Shares Bought2
Shares Sold0
Shares Owned2
Last Price$96.10
Total Return$2.57
Range Today$94.32 - $97.28
52 Week Range$44.68 - $108.27
Market Cap$3.07B
P/E Ratio-

AveXis, Inc. operates as a clinical-stage gene therapy company that engages in the research and development of technology specifically for neurological genetic disease treatment. Its proprietary gene therapy candidate, AVXS-101 has been granted orphan drug designation for the treatment of all types of spinal muscular atrophy and fast track designation for the treatment of spinal muscular atrophy type 1. The company was founded by John D. Harkey, Jr. in 2010 and is headquartered in Chicago, IL.

Open Positions

Buy Date Buy Price Quote Return $ Return % Owners
11-10-17 19:35 $94.79 $96.10 +$1.31 +1.38% funkmasterflexion michrob mistacat
11-10-17 19:36 $94.84 $96.10 +$1.26 +1.33% mistacat

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners